Cardiac Magnetic Resonance in Pulmonary Hypertension-an Update
- PMID: 33184585
- PMCID: PMC7648000
- DOI: 10.1007/s12410-020-09550-2
Cardiac Magnetic Resonance in Pulmonary Hypertension-an Update
Abstract
Purpose of review: This article reviews advances over the past 3 years in cardiac magnetic resonance (CMR) imaging in pulmonary hypertension (PH). We aim to bring the reader up-to-date with CMR applications in diagnosis, prognosis, 4D flow, strain analysis, T1 mapping, machine learning and ongoing research.
Recent findings: CMR volumetric and functional metrics are now established as valuable prognostic markers in PH. This imaging modality is increasingly used to assess treatment response and improves risk stratification when incorporated into PH risk scores. Emerging techniques such as myocardial T1 mapping may play a role in the follow-up of selected patients. Myocardial strain may be used as an early marker for right and left ventricular dysfunction and a predictor for mortality. Machine learning has offered a glimpse into future possibilities. Ongoing research of new PH therapies is increasingly using CMR as a clinical endpoint.
Summary: The last 3 years have seen several large studies establishing CMR as a valuable diagnostic and prognostic tool in patients with PH, with CMR increasingly considered as an endpoint in clinical trials of PH therapies. Machine learning approaches to improve automation and accuracy of CMR metrics and identify imaging features of PH is an area of active research interest with promising clinical utility.
Keywords: CMR; Cardiac MRI; Pulmonary hypertension.
© The Author(s) 2020.
Conflict of interest statement
Conflict of InterestThe authors declare that they no conflict of interest.
Figures
Similar articles
-
Correlation between right ventricular T1 mapping and right ventricular dysfunction in non-ischemic cardiomyopathy.Int J Cardiovasc Imaging. 2018 Jan;34(1):55-65. doi: 10.1007/s10554-017-1113-3. Epub 2017 Mar 29. Int J Cardiovasc Imaging. 2018. PMID: 28357724
-
A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosis.Eur Heart J Cardiovasc Imaging. 2021 Jan 22;22(2):236-245. doi: 10.1093/ehjci/jeaa001. Eur Heart J Cardiovasc Imaging. 2021. PMID: 31998956 Free PMC article.
-
Non-invasive methods for estimating mPAP in COPD using cardiovascular magnetic resonance imaging.Eur Radiol. 2018 Apr;28(4):1438-1448. doi: 10.1007/s00330-017-5143-y. Epub 2017 Nov 16. Eur Radiol. 2018. PMID: 29147768 Free PMC article.
-
Cardiovascular Magnetic Resonance Imaging of Takotsubo Syndrome: Evolving Diagnostic and Prognostic Perspectives.Echocardiography. 2024 Oct;41(10):e15949. doi: 10.1111/echo.15949. Echocardiography. 2024. PMID: 39367775 Review.
-
Role of cardiovascular magnetic resonance in pediatric pulmonary hypertension-novel concepts and imaging biomarkers.Cardiovasc Diagn Ther. 2021 Aug;11(4):1057-1069. doi: 10.21037/cdt-20-270. Cardiovasc Diagn Ther. 2021. PMID: 34527532 Free PMC article. Review.
Cited by
-
Cardiovascular Magnetic Resonance Imaging Patterns in Rare Cardiovascular Diseases.J Clin Med. 2022 Oct 29;11(21):6403. doi: 10.3390/jcm11216403. J Clin Med. 2022. PMID: 36362632 Free PMC article. Review.
-
Cardiothoracic Imaging for Outcome Prediction in Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Endarterectomy or Balloon Pulmonary Angioplasty: A Scoping Review.J Clin Med. 2024 Aug 26;13(17):5045. doi: 10.3390/jcm13175045. J Clin Med. 2024. PMID: 39274257 Free PMC article.
-
Connective tissue disease-associated pulmonary hypertension: A comprehensive review.Pulm Circ. 2023 Dec 11;13(4):e12276. doi: 10.1002/pul2.12276. eCollection 2023 Oct. Pulm Circ. 2023. PMID: 38088955 Free PMC article. Review.
-
Cardiac magnetic resonance assessment of cardiac involvement in autoimmune diseases.Front Cardiovasc Med. 2023 Sep 22;10:1215907. doi: 10.3389/fcvm.2023.1215907. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37808881 Free PMC article. Review.
-
SCMR expert consensus statement for cardiovascular magnetic resonance of acquired and non-structural pediatric heart disease.J Cardiovasc Magn Reson. 2022 Jul 21;24(1):44. doi: 10.1186/s12968-022-00873-1. J Cardiovasc Magn Reson. 2022. PMID: 35864534 Free PMC article. Review.
References
-
- •• Kiely DG, Levin D, Hassoun P, Ivy DD, Jone P-N, Bwika J, et al. EXPRESS: statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI). Pulm Circ. 2019;9(3):2045894019841990. This article provides guidance on the role of the different types of imaging in pulmonary hypertension including cardiac MRI. - PMC - PubMed
-
- Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, et al. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2015;46(4):903–75. - PubMed
-
- Wijeratne DT, Lajkosz K, Brogly SB, Lougheed MD, Jiang L, Housin A, et al. Increasing incidence and prevalence of World Health Organization groups 1 to 4 pulmonary hypertension: a population-based cohort study in Ontario, Canada. Circ Cardiovasc Qual Outcomes. 2018;11:e003973. doi: 10.1161/CIRCOUTCOMES.117.003973. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous